FDA recall D-065-2013

GlaxoSmithKline, LLC. · Class III · drug

Product

Advair HFA (fluticasone propionate/salmeterol) Inhalation Aerosol, 45mcg/21 mcg 60 Actuations INST, NDC 0173-0715-22, Rx only, GlaxoSmithKline, Research Triangle Park, NC 27709.

Reason for recall

Product Lacks Stability: These lots are being recalled due to the failure to meet the particle size distribution specification.

Distribution

Nationwide and Puerto Rico.

Key facts

Status
Terminated
Initiation date
2012-10-24
Report date
2012-12-05
Termination date
2014-09-11
Voluntary/Mandated
Voluntary: Firm initiated
Location
Zebulon, NC, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-065-2013